Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCohort Regulatory News (CHRT)

Share Price Information for Cohort (CHRT)

Share Price is delayed by 15 minutes
Get Live Data
1,240.00    -16.00 (-1.27%)
Bid:
1,228.00
Ask:
1,238.00
Spread: 10.00 (0.814%)
Market Cap: £568.24m
CHRT Live PriceLast checked at - London Stock Exchange

Intraday Cohort Share Chart

Acquisition

1 Oct 2014 07:00

RNS Number : 0900T
Cohort PLC
01 October 2014
Β 

ο»Ώ

01 October 2014

Β 

Cohort plc

("Cohort" or "the Group")

Β 

Cohort plc acquires J+S Ltd

Β 

Β 

Cohort, the independent technology group, is pleased to announce the acquisition of J+S Limited ('J+S' or 'the Company'), an independent systems and in-service support provider for the defence and offshore energy markets, from its shareholders for a cash consideration of Β£12 million.

Highlights:

Β 

Β· Total cash consideration of Β£12m, payable from Cohort's existing resources

Β· J+S provides the Group with new capabilities in defence, offered to the UK Royal Navy and other customers globally, and offshore energy

Β· J+S will be integrated into Cohort's existing subsidiary SEA

Β· Potential to offer enhanced technology solutions, support J+S's growth opportunities and to extend SEA's access to export markets

Β· Acquisition expected to be immediately earnings enhancing

Β 

Overview of J+S Ltd:

J+S is a leading UK supplier of systems and in-service support for the defence and offshore energy markets. Its principal operating site is in Barnstaple and it also has a facility in Aberdeen. Its defence products include sonar systems, torpedo launchers and a range of other naval equipment. J+S has made sales in Canada, Malaysia and the wider Asia Pacific region, with a total of 12 per cent of 2012/13 revenue coming from outside the UK. The Company expects this proportion to increase in 2013/14. Established in 1956, J+S currently employs 137 staff across its two sites.

In the year ended 30 September 2013, J+S booked orders of Β£34.9m (2012: Β£8.8m). This was a record for the Company with a particularly strong performance from its defence business. The year-end order book stood at Β£36.5m (2012: Β£15.0m). It reported an operating profit of Β£1.5m (2012: Β£1.4m) on revenue up 4.4% to Β£13.2m (2012: Β£12.6m) for the year.

J+S expects to deliver turnover of Β£14m for the year to 30 September 2014 with an operating profit of Β£1.5m and Cohort believes growth prospects for subsequent years are strong. The Company's order book at the end of September 2014 is expected to be in excess of Β£33m.

At 30 September 2013, the gross assets of J+S were Β£8.7m and the net assets Β£3.7m. J+S's executive management will remain in place following the transaction, integrated into SEA's management team under Managing Director Stephen Hill.

Background to and reasons for the acquisition:

The acquisition of J+S is in line with the Group's stated strategy to accelerate its growth by making targeted acquisitions, complementing organic growth, whether as stand-alone members of the Group or as "bolt-in" acquisitions to our existing subsidiaries. The Board believes that this strategy of investing the Group's significant cash resources (which stood at over Β£14m as at 31 August 2014) partly in acquisitions will provide enhanced returns to shareholders.

J+S meets our stated criteria for bolt-in acquisitions where we look for businesses with capabilities and/or customer relationships that are closely linked to one of our existing subsidiaries. J+S's defence capabilities and products, notably its sonar array products, well-established manufacturing capability and long-term customer support relationships, are highly complementary to SEA's. We would expect to integrate J+S fully within SEA, leading to both cost savings and benefits from shared access to markets and technologies.

J+S's established production capability will be able to meet SEA's growing needs for submarine communication and other system manufacture. SEA's expertise in certain technology areas offers the potential for enhanced product offerings. The acquisition of J+S will extend SEA's reach internationally, by building on the strong foothold J+S has in Canada, Malaysia and the wider Asia Pacific region. It also brings a growing capability in adjacent markets including offshore energy.

Terms of the acquisition:

J+S was acquired from its shareholders, comprising David Jeffries, Chairman, and a number of other former and current employees, on a cash free / debt free basis for a consideration of Β£12m. This will be paid using Cohort's existing financial resources which included over Β£14m of net cash as at 31 August 2014 (after payment of the Β£6.0m initial consideration for the MCL transaction). Cohort retains unutilised banking facilities comprising an overdraft facility of Β£7.5m.

Andrew Thomis, Chief Executive Officer of Cohort, said:

"The acquisition of J+S represents Cohort's second significant step forward in recent months, following the acquisition of MCL in July. By integrating J+S into SEA, we aim to accelerate the growth of the combined business by enhancing its product and service offerings and broadening its international reach. The transaction will consolidate SEA's position as a leading international provider of naval defence technology.

"Overall, the two acquisitions have together substantially increased the scale, breadth and reach of Cohort's portfolio and are expected to be immediately earnings enhancing. We continue to look for attractive acquisition opportunities while focusing on integrating both businesses and delivering the synergies and growth we have identified."

An analyst conference call will take place at 9.30am this morning. To register please contact MHP (0203 128 8771 or cohort@mhpc.com)

An interview on today's announcement with the CEO of Cohort PLC, Andrew Thomis, will be available at 10:30am via the following link: http://www.brrmedia.co.uk/event/127479

Β 

Ends

Β 

For further information please contact:

Cohort plc

0118 909 0390

Andy Thomis, Chief Executive

Β 

Simon Walther, Finance Director

Β 

Investec Bank plc

020 7597 5970

Keith Anderson / Daniel Adams

Β 

MHP Communications Limited

020 3128 8100

Reg Hoare / Vicky Watkins

Β 

Β 

NOTES TO EDITORS

Cohort plc

Β 

Cohort is an independent technology group working primarily for defence (air, land and sea), wider government and industry clients, through four market-facing subsidiary companies:

Β 

MASS - a specialist systems house with considerable experience in the defence market and a focus on electronic warfare operational support and secure information systems. Based in Cambridgeshire, MASS was acquired by Cohort in August 2006;

Β 

MCL - an expert in electronic and surveillance technology design and manufacturing, product and in the field support and training for a range of specialist UK end users, including the MOD and other governmental agencies. Based in Surrey, MCL has been part of the Group since July 2014;

Β 

SCS - a defence technical advisory business, combining technical expertise with practical experience and domain knowledge. Owned by Cohort since flotation in March 2006;

Β 

SEA - an advanced surveillance systems and software house with hardware development capability operating in the defence, transport and offshore energy market sectors. Acquired by Cohort in October 2007.

Β 

Cohort was admitted to London's Alternative Investment Market in March 2006. It has its headquarters in Berkshire and employs in total around 500 core staff there and at its other operating company sites in Bristol, Cambridgeshire, Lincolnshire, Somerset and Surrey.

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
ACQUROARSVAKOUR
Date   Source Headline
16th Sep 20245:34 pmRNSHolding(s) in Company
2nd Sep 20245:08 pmRNSTotal Voting Rights
2nd Sep 202411:32 amRNSHolding(s) in Company
27th Aug 20245:54 pmRNSBlock listing six monthly return
21st Aug 20247:00 amRNSAnnual Report and Notice of Annual General Meeting
19th Aug 20243:48 pmRNSDirector/PDMR Shareholding
16th Aug 202412:10 pmRNSHolding(s) in Company
12th Aug 20244:22 pmRNSDirector/PDMR Shareholding
2nd Aug 20242:30 pmRNSDirector/PDMR Shareholding
1st Aug 202411:43 amRNSTotal Voting Rights
29th Jul 20249:45 amRNSDirector/PDMR Shareholding
23rd Jul 20245:04 pmRNSDirector/PDMR Shareholding
17th Jul 20247:01 amRNSContract win
17th Jul 20247:00 amRNSFinal Results
15th Jul 20247:00 amRNSContract Award
11th Jul 20247:00 amRNSNotice of Results
1st Jul 20249:33 amRNSTotal Voting Rights
5th Jun 202410:59 amRNSEBT Purchase of Shares
31st May 20243:17 pmRNSTotal Voting Rights
23rd May 20241:30 pmRNSEBT Purchase of Shares
23rd May 20247:00 amRNSFull Year Trading Update
20th May 20244:01 pmRNSEBT Purchase of Shares
14th May 20242:10 pmRNSEBT Purchase of Shares
7th May 20245:24 pmRNSEBT Purchase of Shares
3rd May 202411:44 amRNSDirector/PDMR Shareholding
1st May 20245:17 pmRNSDirector/PDMR Shareholding
1st May 20245:11 pmRNSTotal Voting Rights
30th Apr 20247:00 amRNSBlock Listing Application
30th Apr 20247:00 amRNSSite visit to SEA
15th Apr 20247:00 amRNSDirector/PDMR Shareholding
8th Apr 20242:19 pmRNSDirector/PDMR Shareholding
2nd Apr 20243:19 pmRNSBlock Listing Six Monthly Return
2nd Apr 20243:17 pmRNSTotal Voting Rights
28th Mar 20242:06 pmRNSHolding(s) in Company
27th Mar 20244:00 pmRNSDirector/PDMR Shareholding
26th Mar 20247:00 amRNSContract Win
19th Mar 20249:43 amRNSContract win
13th Mar 202410:49 amRNSDirector/PDMR Shareholding
1st Mar 20247:00 amRNSTotal Voting Rights
26th Feb 20244:28 pmRNSBlock listing six monthly return
16th Feb 202412:38 pmRNSDirector/PDMR Shareholding
1st Feb 202410:02 amRNSTotal Voting Rights
29th Jan 20247:00 amRNSContract Win
17th Jan 20243:25 pmRNSDirector/PDMR Shareholding
15th Jan 20247:00 amRNSInterim Report 2023
2nd Jan 202412:05 pmRNSTotal Voting Rights
22nd Dec 202312:07 pmRNSHolding(s) in Company
13th Dec 20237:01 amRNSDirectorate Change
13th Dec 20237:00 amRNSHalf Year Results
7th Dec 20237:00 amRNSEquity Development Presentation on 13 December

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.